102-93-2 | 3-Phenyl-propionamide

Packsize	Purity	Availability	Price	Discounted Price
250mg	98%	in stock	$12.00	$9.00
1g	98%	in stock	$17.00	$12.00
5g	98%	in stock	$44.00	$31.00
10g	98%	in stock	$77.00	$54.00
25g	98%	in stock	$154.00	$108.00
100g	98%	in stock	$573.00	$402.00

Description

• Catalog Number: AA07908
• Chemical Name: 3-Phenyl-propionamide
• CAS Number: 102-93-2
• Molecular Formula: C9H11NO
• Molecular Weight: 149.1897
• MDL Number: MFCD00025535
• SMILES: NC(=O)CCc1ccccc1
• NSC Number: 229316

Computed Properties

• Complexity: 128
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 11
• Hydrogen Bond Acceptor Count: 1
• Hydrogen Bond Donor Count: 1
• Rotatable Bond Count: 3
• XLogP3: 0.9

Literature

• Design, synthesis, and biological evaluation of phenylpropanamides as novel transient receptor potential vanilloid 1 antagonists.

  Archives of pharmacal research 20090901

• One-pot synthesis of benzylacetamide from oxime under ultrasound irradiation.

  Ultrasonics sonochemistry 20090601

• Alkylamine sensing using langmuir-blodgett films of n-alkyl-N-phenylamide-substituted zinc porphyrins.

  The journal of physical chemistry. B 20080911

• (S)-1,5-Dibenzyl-3-tert-butyl-imidazol-idin-4-one.

  Acta crystallographica. Section E, Structure reports online 20080701

• Design and synthesis of 3-arylpyrrolidine-2-carboxamide derivatives as melanocortin-4 receptor ligands.

  Bioorganic & medicinal chemistry letters 20080315

• Aromatic chlorination of omega-phenylalkylamines and omega-phenylalkylamides in carbon tetrachloride and alpha,alpha,alpha-trifluorotoluene.

  Organic & biomolecular chemistry 20060721

• Search for constituents with neurotrophic factor-potentiating activity from the medicinal plants of paraguay and Thailand.

  Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20040701

• Design and synthesis of highly potent benzodiazepine gamma-secretase inhibitors: preparation of (2S,3R)-3-(3,4-difluorophenyl)-2-(4-fluorophenyl)-4- hydroxy-N-((3S)-1-methyl-2-oxo-5- phenyl-2,3-dihydro-1H-benzo[e][1,4]-diazepin-3-yl)butyramide by use of an asymmetric Ireland-Claisen rearrangement.

  Journal of medicinal chemistry 20030605

• Update on medical treatment of ejaculatory disorders.

  International journal of andrology 20021201